Chemotherapy Induced Pain Pipeline Review, H2 2012 New Report
Chemotherapy Induced Pain - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Pain.
View full press release